SquareMind secures EIC Accelerator backing for SWAN skin-cancer detection project
SquareMind's SWAN project was backed under the European Innovation Council Accelerator blended-finance programme.
Evidence notes
- SquareMind's SWAN project received backing through the European Innovation Council Accelerator blended-finance programme.
- The project focused on scaling full-body imaging and dermatology automation for earlier skin-cancer detection.
- CORDIS lists the grant agreement signature on 9 June 2022 and the project period from July 2022 through December 2024.
Company context
SquareMind is a Paris-based medical robotics company developing Swan, a robotic full-body dermoscopy system for dermatology. Swan automates standardized skin imaging and pairs the scan workflow with AI software for lesion mapping, change detection and physician review.